By Bobbi Nodell
In what is being called the first-ever test of open-source drug-discovery, researchers from around the world have successfully identified compounds to pursue in treating and preventing parasite-borne illnesses such as malaria as well as cancer.
Congratulations to Affiliate Associate Professor Joseph Smith for his work on a major malaria discovery, highlighted in this week's Association of Schools and Programs of Public Health (ASPPH) newsletter. Dr. Smith works is based in the Center for Infectious Disease Research and works with our Pathobiology program.
By Maggie Fox
Researchers have developed a new, long-acting malaria drug that they believe may help fight one of the world's biggest killers.
The drug, still known by its experimental name "DSM265," can stop the malaria parasite at several stages in its life cycle, the researchers report in the journal Science Translational Medicine. Tests in people have begun.